Integra LifeSciences IART FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's FX effect on cash?
- Integra LifeSciences (IART) reported FX effect on cash of -$1.49M in Q1 2026.
- How has Integra LifeSciences's FX effect on cash changed year-over-year?
- Integra LifeSciences's FX effect on cash decreased by 132.9% year-over-year, from $4.53M to -$1.49M.
- What is the long-term trend for Integra LifeSciences's FX effect on cash?
- Over 2 years (2023 to 2025), Integra LifeSciences's FX effect on cash has grown at a 114.2% compound annual growth rate (CAGR), from $4.1M to $18.82M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.